======= CYP2W1 ======= == Gene Information == * **Official Symbol**: CYP2W1 * **Official Name**: cytochrome P450 family 2 subfamily W member 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=54905|54905]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q8TAV3|Q8TAV3]] * **Interactions**: [[https://thebiogrid.org/search.php?search=CYP2W1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20CYP2W1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/615967|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: Seems to have broad catalytic activity towards several chemicals, including polycyclic aromatic hydrocarbon dihydrodiols and aromatic amines (PubMed:16551781, PubMed:24278521). Active also in the metabolism of indoline substrates and is able to activate aflatoxin B1 into cytotoxic products (PubMed:20805301). Furthermore, it seems to be involved in the oxydation of lysophospholipids and fatty acids (PubMed:22591743). {ECO:0000269|PubMed:16551781, ECO:0000269|PubMed:20805301, ECO:0000269|PubMed:22591743, ECO:0000269|PubMed:24278521}. |p450| |aflatoxin B1 metabolic process| |mycotoxin metabolic process| |aflatoxin metabolic process| |organic heteropentacyclic compound metabolic process| |ether metabolic process| |toxin metabolic process| |exogenous drug catabolic process| |oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen| |steroid hydroxylase activity| |secondary metabolic process| |cellular ketone metabolic process| |xenobiotic metabolic process| |iron ion binding| |heme binding| |drug catabolic process| |cellular response to xenobiotic stimulus| |response to xenobiotic stimulus| |endoplasmic reticulum lumen| |drug metabolic process| |cell surface| |intracellular membrane-bounded organelle| |endoplasmic reticulum membrane| |oxidation-reduction process| |response to drug| |organic acid metabolic process| |small molecule metabolic process| |cellular catabolic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp426|FBS-Wisent 0.1 R07 exp426]]|-1.86| |[[:results:exp184|Ixabepilone 0.004 to 0.005μM on day4 R04 exp184]]|-1.72| |[[:results:exp289|Hydroxyurea 15μM R06 exp289]]|1.79| |[[:results:exp539|42°C R08 exp539]]|1.81| |[[:results:exp93|DABN racemic mixture R03 exp93]]|2.07| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 9810 * **Expression level (log2 read counts)**: 0.06 {{:chemogenomics:nalm6 dist.png?nolink |}}